Utama › Kanser Pundi Kencing
Kajian klinikal Kanser Pundi Kencing sedang mengambil peserta di AS
142 kajian untuk Kanser Pundi Kencing sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY35 kajian
- Nashville, TN31 kajian
- Houston, TX31 kajian
- Dallas, TX27 kajian
- Boston, MA26 kajian
- Washington, DC26 kajian
- Los Angeles, CA24 kajian
- Baltimore, MD24 kajian
- St. Louis, MO22 kajian
- Philadelphia, PA21 kajian
- Seattle, WA21 kajian
- Edison, NJ21 kajian
- Chicago, IL21 kajian
- Durham, NC20 kajian
- Columbus, OH19 kajian
- Cleveland, OH18 kajian
- Atlanta, GA16 kajian
- Queens, NY16 kajian
- Baldwin Park, CA14 kajian
- San Francisco, CA13 kajian
- Portland, OR13 kajian
- San Antonio, TX13 kajian
- Rochester, MN12 kajian
- Kansas City, KS12 kajian
- Austin, TX12 kajian
- Orange, CA12 kajian
- Grand Rapids, MI12 kajian
- Birmingham, AL11 kajian
- San Diego, CA11 kajian
- Milwaukee, WI11 kajian
- Denver, CO11 kajian
- Irvine, CA11 kajian
- Detroit, MI11 kajian
- New Rochelle, NY11 kajian
- Staten Island, NY11 kajian
- Minneapolis, MN11 kajian
- Oklahoma City, OK11 kajian
- Omaha, NE10 kajian
- Myrtle Beach, SC10 kajian
- Kansas City, MO10 kajian
Mengikut negeri
- Alabama11 kajian
- Alaska3 kajian
- Arizona20 kajian
- Arkansas15 kajian
- California54 kajian
- Colorado20 kajian
- Connecticut9 kajian
- Delaware4 kajian
- Florida38 kajian
- Georgia19 kajian
- Idaho6 kajian
- Illinois30 kajian
- Indiana14 kajian
- Iowa12 kajian
- Kansas17 kajian
- Kentucky7 kajian
- Louisiana13 kajian
- Maryland36 kajian
- Massachusetts31 kajian
- Michigan25 kajian
- Minnesota24 kajian
- Mississippi3 kajian
- Missouri27 kajian
- Montana7 kajian
- Nebraska11 kajian
- Nevada5 kajian
- New Hampshire3 kajian
- New Jersey26 kajian
- New Mexico3 kajian
- New York41 kajian
- North Carolina26 kajian
- North Dakota4 kajian
- Ohio36 kajian
- Oklahoma12 kajian
- Oregon14 kajian
- Pennsylvania27 kajian
- Rhode Island4 kajian
- South Carolina16 kajian
- South Dakota4 kajian
- Tennessee34 kajian
- Texas51 kajian
- Utah14 kajian
- Vermont3 kajian
- Virginia24 kajian
- Washington25 kajian
- West Virginia5 kajian
- Wilayah Columbia17 kajian
- Wisconsin17 kajian
- Wyoming4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Evaluation for NCI Surgery Branch Clinical Research Protocols
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00001823A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07232602En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06764095A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07090499Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06263153Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07664397Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07061964Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06470282Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06394570Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07667335Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT00026884Patient-Centered Surgical Prehabilitation
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 85 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05715684The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382DK222 Study at Hopkins
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07421700Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.